Upcoming Clinical Trials
Navigation for This Section: Clinical Trials Links
Study C0743T08: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Efficacy and Safety of CNTO 1275 in the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
Protocol ACD3331g: A Phase II, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of SC EFALIZUMAB 1.0 mg/kg/wk in Subjects 18 years and Older with Moderate to Severe Atopic Dermatitis Who are Candidates for Systemic Therapy and Cannot be Safely or Adequately Controlled with Topical Therapies.
Psoriasis Patient Compliance Enhancement Model
 |
|
Derm Intranet